Content
09/07/2017
St. Louis, MO USA
NewLeaf Symbiotics
completed $30 million Series C Round funding. Investors include
S2G Ventures (lead), Lewis & Clark Ventures, Open Prairie Ventures, Pangaea Ventures, RockPort Capital, Yard Ventures.
About
NewLeaf Symbiotics is the industry’s undisputed Ag Biotech leader and pioneer of PPFM technology. The proud Champions of Pink Performance, NewLeaf works to harness pink-pigmented facultative methylotrophs – PPFMs – into actionable solutions to challenges around yield, crop protection, nutrient use efficiency and methane mitigation, with the intent of helping farmers do more with less as they work to feed a growing population.
Startup
Sector:
AgTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
